The relationship between personality disorder dysfunctional beliefs, medication adherence and clinical features in schizophrenia spectrum disorders


AYDIN E. F., CEYHUN H. A., ŞAHİNGÖZ M., TUYGAR OKUTUCU F., Kartal C.

10th International Congress of Cognitive Psychotherapy, Roma, İtalya, 13 - 15 Mayıs 2021, ss.42-43

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Roma
  • Basıldığı Ülke: İtalya
  • Sayfa Sayıları: ss.42-43
  • Atatürk Üniversitesi Adresli: Evet

Özet

INTRODUCTION Medication adherence has been defined as the extent to which a person’s behavior coincides with the medical advice given. Medication nonadherence is common among patients with schizophrenia spectrum disorders(SSD) due to a variety of factors including including lack of insight, psychopathology, substance use disorder, issues associated with treatment, stigma and cultural influences. However, whether medication adherence is determined by personality disorders in schizophrenia spectrum disorders(SSD) remains poorly known. Here, we aimed to assess effects of personality disorder dysfunctional beliefs upon medication adherence and clinical features in outpatients with SSD. METHODS Cross sectional data were collected. Participants were outpatients who were using only oral medications with SSD according to DSM-IV. 37 outpatients were enrolled in the study. Patients participated in an interview and sociodemoghraphic, clinical and treatment variables were collected. The 4- item Morisky Medication Adherence Scale(MMAS) was used to assess medication adherence. According to MMAS scores, patients’ medication adherence have been grouped as high, moderate and poor. Personality disorder dysfunctional beliefs were evaluated by Personality Belief Questionnaire-Short Form (PBQ-SF). 10.45 – 12.15 ROOM 7 Symposium 59 43 FRIDAY, 14th May 2021 RESULTS 11(29,7%) outpatients were reported as high, 20(54,1%) outpatients were reported as moderate and 6(16,2%) outpatients were reported as poor medication adherence group, respectively. Poor medication adherence group had higher total personality disorder dysfunctional beliefs scores than other medication adherence groups. However, no significant association was found between each type of personality disorder dysfunctional beliefs scores or total personality disorder dysfunctional beliefs scores and any medication adherence groups. Total number of hospitalization was significantly asssociated with dependent personality disorder dysfunctional beliefs (p<0.01) and borderline personality disorder dysfunctional beliefs (p<0.03). Besides this, number of suicide attempts were significanly related with dependent personality disorder dysfunctional beliefs (p<0.03). DISCUSSION Low medication adherence group showed tendency to have higher total personality disorder dysfunctional beliefs. This could be an expected finding, however no significant association was found between total personality disorder dysfunctional beliefs, each type of type personality disorder dysfunctional beliefs and each type of medication adherence group. Also total number of hospitalization and total number of suicide attempts were significantly related with some specific personality disorder dysfunctional beliefs. CONCLUSION Evaluation and focusing on personality disorder dysfunctional beliefs as part of psychosocial interventions in SSD outpatients may be useful in medication adherence, reducing number of suicide attempts and hospitalization numbers. However, these results should be evaluated in future studies